Esophageal Cancer: Results of the Trimodal Approach in a Medium-Volume Multidisciplinary Unit

Discussion / Conclusion Our data reinforces the idea that neoad juvant CRT contribute d to tumor shr inkage, as is documented by the number of positive pR. This would in turn lead to higher R0 rates, TNMdownstaging and longer survival. We achieved surgery resu lts and treatment outcomes simi lar to h igher-volume centers. Since most of the patients have le sst han3 years fo llow-up, we expect that the overall and disea se free surv ivaloutcomes wi ll improve. The trimoda l approach for e sophageal cancer therefore offers pr omising re sult s even in smaller multidisciplinary units. Table 1. Patient Characteristics Age, mean 58,95 Male/Female 32/5 86%/14% Type of Tumour Squamous Cell Carcinoma 26 70,3% Adenocarcinoma 9 24,3% Neuro-Endocrine 2 5,4% Locationof Primary Tumour Middle Third 12 32,4% Lower Third 25 67,6% cTNMStage I 3 8,1% II 5 13,5% III 29 78,4% Introduction Esophageal cancer is a devastating d isease , associated with a poor progno sis. Neoad juvant Chemo-Radiotherapy (CRT) a ims to reduce the bulk of the primary tumor before surgery in or der to facilitate highe r curative resection rates , achieve better locorregional control and prevent micrometastasis. We pre sent the results of a trimoda l approach performed by a medium-volume multid iscipl inary unit.